NCT03504735View on ClinicalTrials.gov

Caduet and TLC Intervention in Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 1, 2005

Primary Completion Date

January 1, 2009

Study Completion Date

February 28, 2016

Conditions
Metabolic Syndrome
Interventions
BEHAVIORAL

Therapeutic Lifestyle Change

Monthly consult with a dietitian and fitness instructor.

DRUG

Caduet Pill

Take once daily.

DRUG

Placebo

Take once daily.

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

University of Texas Southwestern Medical Center

OTHER

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03504735 - Caduet and TLC Intervention in Metabolic Syndrome | Biotech Hunter | Biotech Hunter